AD-2646 (LCL102) is a ceramide analog that kills leukemia T cells (EC50: 40 μM); it triggers cleavage of caspase-8, -9, and -3 as well as the caspase substrate PARP; it acts as a ceramidase inhibitor and induces accumulation of endogenous ceramides due to disrupted ceramide metabolism.